GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » Other Current Liabilities

Arovella Therapeutics (ASX:ALA) Other Current Liabilities

: A$0.21 Mil (As of Dec. 2023)
View and export this data going back to 2002. Start your Free Trial

Arovella Therapeutics's other current liabilities for the quarter that ended in Dec. 2023 was A$0.21 Mil.

Arovella Therapeutics's quarterly other current liabilities increased from Dec. 2022 (A$0.26 Mil) to Jun. 2023 (A$0.46 Mil) but then declined from Jun. 2023 (A$0.46 Mil) to Dec. 2023 (A$0.21 Mil).

Arovella Therapeutics's annual other current liabilities increased from Jun. 2021 (A$0.39 Mil) to Jun. 2022 (A$0.63 Mil) but then declined from Jun. 2022 (A$0.63 Mil) to Jun. 2023 (A$0.46 Mil).


Arovella Therapeutics Other Current Liabilities Historical Data

The historical data trend for Arovella Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => - [6] => - [7] => - [8] => - [9] => - )
Arovella Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Current Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arovella Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Arovella Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Arovella Therapeutics (ASX:ALA) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (ASX:ALA) Headlines

No Headlines